Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy
- Journal
- ACS Nano
In The Last Decade
doi.org/10.1021/nn405724x →Countries where authors are citing Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy
This map shows the geographic impact of Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy more than expected).
Fields of papers citing Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy
This network shows the impact of Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy.
About Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy
This paper, published in 2014, received 430 indexed citations . Written by Vipul Gujrati, Sung-Hyun Kim, Sang‐Hyun Kim, Jung Joon Min, Hyon E. Choy and Sangyong Jon covering the research area of Biotechnology, Ecology and Microbiology. It is primarily cited by scholars working on Molecular Biology (227 citations), Microbiology (188 citations) and Biomedical Engineering (165 citations). Published in ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1021/nn405724x.